白细胞增多和淋巴细胞减少对冠状病毒疾病严重程度的预后价值。
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
出版信息
Emerg Infect Dis. 2020 Aug;26(8):1839-1841. doi: 10.3201/eid2608.201160. Epub 2020 May 8.
Abstract
To evaluate lymphopenia as a marker for coronavirus disease severity, we conducted a meta-analysis of 10 studies. Severe illness was associated with lower lymphocyte and higher leukocyte counts. Using these markers for early identification of patients with severe disease may help healthcare providers prioritize the need to obtain therapy.
摘要
为了评估淋巴细胞减少作为冠状病毒疾病严重程度的标志物，我们对 10 项研究进行了荟萃分析。严重疾病与较低的淋巴细胞计数和较高的白细胞计数相关。使用这些标志物早期识别严重疾病患者，可能有助于医疗保健提供者确定获得治疗的必要性。
相似文献
1
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.白细胞增多和淋巴细胞减少对冠状病毒疾病严重程度的预后价值。
Emerg Infect Dis. 2020 Aug;26(8):1839-1841. doi: 10.3201/eid2608.201160. Epub 2020 May 8.
2
Laboratory findings of COVID-19: a systematic review and meta-analysis.COVID-19 的实验室检测结果：系统评价和荟萃分析。
Scand J Clin Lab Invest. 2020 Oct;80(6):441-447. doi: 10.1080/00365513.2020.1768587. Epub 2020 May 23.
3
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
4
Papa Giovanni XXIII Bergamo Hospital at the time of the COVID-19 outbreak: Letter from the warfront….新冠疫情爆发时的教皇若望二十三世贝加莫医院：来自抗疫前线的信……
Int J Lab Hematol. 2020 Jun;42 Suppl 1:8-10. doi: 10.1111/ijlh.13207.
5
Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.利用 IL-2R/淋巴细胞预测 COVID-19 患者的临床进展。
Clin Exp Immunol. 2020 Jul;201(1):76-84. doi: 10.1111/cei.13450. Epub 2020 May 15.
6
Viral and host factors related to the clinical outcome of COVID-19.与 COVID-19 临床结果相关的病毒和宿主因素。
Nature. 2020 Jul;583(7816):437-440. doi: 10.1038/s41586-020-2355-0. Epub 2020 May 20.
7
The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel?严重 COVID-19 患者外周血炎症细胞的潜在变化及其预测作用：一个指标？
Clin Chim Acta. 2020 Sep;508:122-129. doi: 10.1016/j.cca.2020.05.027. Epub 2020 May 14.
8
Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis.白细胞增多和 C 反应蛋白升高对预测严重 2019 年冠状病毒病（COVID-19）的价值：系统评价和荟萃分析。
Clin Chim Acta. 2020 Oct;509:235-243. doi: 10.1016/j.cca.2020.06.008. Epub 2020 Jun 10.
9
Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.中国武汉 116 例 COVID-19 住院患者的临床特征：一项以医院为中心、回顾性、观察性研究。
BMC Infect Dis. 2020 Oct 22;20(1):787. doi: 10.1186/s12879-020-05452-2.
10
Atypical lymphocyte morphology in SARS-CoV-2 infection.新型冠状病毒肺炎感染中的非典型淋巴细胞形态
Pathol Res Pract. 2020 Sep;216(9):153063. doi: 10.1016/j.prp.2020.153063. Epub 2020 Jun 10.
引用本文的文献
1
Predictive value of the neutrophil-to-lymphocyte ratio for epidural labor analgesia-associated intrapartum fever: a retrospective single-center study.中性粒细胞与淋巴细胞比值对硬膜外分娩镇痛相关产时发热的预测价值：一项回顾性单中心研究
BMC Anesthesiol. 2025 Feb 22;25(1):96. doi: 10.1186/s12871-025-02972-9.
2
Assessing the impact of comorbidities on disease severity in COVID-19 patients requires consideration of age.评估合并症对新冠肺炎患者疾病严重程度的影响需要考虑年龄因素。
Medicine (Baltimore). 2025 Jan 31;104(5):e41360. doi: 10.1097/MD.0000000000041360.
3
Predicting Intensive Care Unit Admission in COVID-19-Infected Pregnant Women Using Machine Learning.使用机器学习预测COVID-19感染孕妇的重症监护病房入院情况。
J Clin Med. 2024 Dec 17;13(24):7705. doi: 10.3390/jcm13247705.
4
Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the Pandemic.血清TARC水平作为大流行期间奥密克戎变异株时期COVID-19严重疾病的预测标志物
Intern Med. 2025 Feb 1;64(3):367-374. doi: 10.2169/internalmedicine.4276-24. Epub 2024 Nov 21.
5
Adult Respiratory Syncytial Virus Infection: Defining Incidence, Risk Factors for Hospitalization, and Poor Outcomes, a Regional Cohort Study, 2016-2022.成人呼吸道合胞病毒感染：确定发病率、住院风险因素及不良结局，一项2016 - 2022年的区域队列研究
Pathogens. 2024 Aug 31;13(9):750. doi: 10.3390/pathogens13090750.
6
Acute Kidney Injury in the Context of COVID-19: An Analysis in Hospitalized Mexican Patients.2019冠状病毒病背景下的急性肾损伤：墨西哥住院患者分析
Infect Dis Rep. 2024 May 16;16(3):458-471. doi: 10.3390/idr16030034.
7
Analysis of Risk Factors for Death in the Coronavirus Disease 2019 (COVID-19) Population: Data Analysis from a Large General Hospital in Anhui, China.2019年冠状病毒病（COVID-19）患者死亡危险因素分析：来自中国安徽某大型综合医院的数据分析
Cureus. 2024 May 10;16(5):e60069. doi: 10.7759/cureus.60069. eCollection 2024 May.
8
High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 and CD8 memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.高频率的α型普通感冒冠状病毒/SARS-CoV-2 交叉反应性功能性 CD4 和 CD8 记忆 T 细胞与未接种疫苗的 COVID-19 患者免受有症状和致命 SARS-CoV-2 感染有关。
Front Immunol. 2024 Mar 28;15:1343716. doi: 10.3389/fimmu.2024.1343716. eCollection 2024.
9
Assessing the Association between Biomarkers and COVID-19 Mortality Using the Joint Modelling Approach.使用联合建模方法评估生物标志物与COVID-19死亡率之间的关联。
Life (Basel). 2024 Mar 6;14(3):343. doi: 10.3390/life14030343.
10
A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2.使用简单血液学参数评估 COVID-19 住院患者使用巴瑞替尼获益的风险概况：适应性 COVID-19 治疗试验-2 的事后分析。
Ann Intern Med. 2024 Mar;177(3):343-352. doi: 10.7326/M23-2593. Epub 2024 Feb 27.
本文引用的文献
1
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
2
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options.2019年冠状病毒病的治疗：早期及新出现的治疗选择综述
Open Forum Infect Dis. 2020 Mar 23;7(4):ofaa105. doi: 10.1093/ofid/ofaa105. eCollection 2020 Apr.
3
A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic.新冠疫情期间呼吸机及重症监护床位分配框架
JAMA. 2020 May 12;323(18):1773-1774. doi: 10.1001/jama.2020.5046.
4
Clinical features and treatment of COVID-19 patients in northeast Chongqing.重庆东北部地区 COVID-19 患者的临床特征和治疗方法。
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.
5
Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.新型冠状病毒（COVI-19 或 SARS-CoV-2）诱导促炎细胞因子（IL-1 和 IL-6）和肺部炎症：抗炎策略。
J Biol Regul Homeost Agents. 2020;34(2):327-331. doi: 10.23812/CONTI-E.
6
Hematologic parameters in patients with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染患者的血液学参数
Am J Hematol. 2020 Jun;95(6):E131-E134. doi: 10.1002/ajh.25774. Epub 2020 Mar 19.
7
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virus.流感病毒所致肺炎住院患者淋巴细胞减少的临床意义
Crit Care. 2019 Oct 29;23(1):330. doi: 10.1186/s13054-019-2608-1.
Zotero 插件